Literature DB >> 10231875

Characterization of endotoxin and cationic liposome interaction.

S W Poxon1, J A Hughes.   

Abstract

The objective of this study was to characterize the interaction of endotoxin with cationic liposomes used in nonviral gene delivery. Endotoxin-cationic liposome interaction was characterized using fluorescent anisotropy, and the Limulus amebocyte lysate (LAL) assay. Cellular toxicity of endotoxin-cationic liposome complex was examined using a dimethylthiazol diphenyltetrazolium bromide (MTT) assay. The effect of endotoxin on the lipid-DNA complex and subsequent transfection into COS-1 cells was also examined. A competitive interaction occurred between fluoroscein isothiocyanate (FITC)-labeled endotoxin and plasmid DNA for binding dioleoyl glycero trimethylammonium propane:dioleoyl glycero phosphoethanolamine (DOTAP:DOPE) liposomes using fluorescent anisotropy techniques. The LAL assay demonstrated no change in endotoxin activity upon interaction with liposomes. No loss of COS cell viability was detected via the MTT assay during a 5-hr exposure to endotoxin. Transient transfection studies indicate that increasing levels of endotoxin lowered activity more than 90% at 50,000 endotoxin units (EU)/ml. Endotoxin and cationic liposomes interact mainly by an electrostatic attraction. Endotoxin contamination can potentially impact transfection efficiency via competition with plasmid DNA for cationic liposome binding by increasing transfection variability at 50 EU/ml, a concentration of endotoxin contamination that can occur with small-scale plasmid preparations used for in vitro cell transfections, but would not be expected with typical GLP or GMP preparations used in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231875     DOI: 10.1081/pdt-100101348

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  3 in total

1.  Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.

Authors:  Marina A Dobrovolskaia; Barry W Neun; Jeffrey D Clogston; Hui Ding; Julia Ljubimova; Scott E McNeil
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

2.  Biophysical characterization of triacyl monosaccharide lipid a partial structures in relation to bioactivity.

Authors:  Klaus Brandenburg; Motohiro Matsuura; Holger Heine; Mareike Müller; Makato Kiso; Hideharu Ishida; Michel H J Koch; Ulrich Seydel
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

Review 3.  Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Authors:  Marina A Dobrovolskaia
Journal:  J Control Release       Date:  2015-09-05       Impact factor: 9.776

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.